NCT03885765Completed
Complication and Lung Function Impairment Prediction Using Perfusion and CT Air Trapping
Complication and Lung Function Impairment Prediction Using Perfusion and CT Air Trapping (CLIPPCAIR): Protocol for the Development and Validation of a Novel Algorithm for Post-resection Lung Function
Source: ClinicalTrials.gov · Last updated 22 Jun 2025
Brief summary (registry, in English)
The primary objective of the CLIPPCAIR study is to construct and validate a new algorithm for predicting post-operative forced expiratory volume in 1 second (FEV1) values for lung resection candidates; this new model will be based on data derived from a thoracic CT scan with injection of contrast media.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 160 (actual)
- First submitted
- 19 Mar 2019
- Start date
- 21 Sept 2020
- Primary completion date
- 18 Apr 2025
- Lead sponsor
- University Hospital, Montpellier
- Diseases
- Lung cancer
- NCT number
- NCT03885765
What you commit to
- Study type: Observational
- Participants enrolled: 160
- From 21 Sept 2020 to the primary completion date, 18 Apr 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Contraindication to surgery or iodine injection
Other illness
- Participation in another study that may affect the results of the present study (anti-cancer treatment studies are allowed)
Other
- Patient in an exclusion period determined by another protocol
- Patient under legal or judicial protection
- Pregnant or lactating women
Who the study is looking for
- Patient diagnosed with non-small cell lung cancer
- Indication for pulmonary excision surgery
- Patient requiring a more recent pre-surgical computed tomography scan (CT scan)
- The patient has been correctly informed about the study and has signed the consent form
- The patient is affiliated with or a beneficiary of the French single-payer social security programme (national health insurance)
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| CHU Montpellier Coordinator of this site? Confirm its status | Montpellier | France | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.